| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.009 |